QUINTESSENCE BIOSCIENCES
Quintessence Biosciences, Inc., a biopharmaceutical company, develops novel protein-based therapeutics as anti-cancer agents. The company’s products include Evade RNase QBI-139 that causes tumor growth inhibition in breast, colorectal, non-small cell lung, ovarian, pancreatic, and prostate cancers; targeted EVade ribonucleases, a tumor targeting therapy; and EVade ribonuclease zymogens that are inactive enzyme precursors that proteolytically cleave to manifest their catalytic activity. Its products are based on the Evade ribonuclease technology that allows for the engineering of human proteins (ribonucleases) for the treatment of human diseases.
QUINTESSENCE BIOSCIENCES
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2000-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.quintbio.com
Total Employee:
11+
Status:
Closed
Contact:
6084412952
Email Addresses:
[email protected]
Total Funding:
3.13 M USD
Technology used in webpage:
Amazon Google Maps Google Maps API Amazon California Region
Current Employees Featured
Founder
Newest Events participated
Participated in AGC 13th Annual West Coast Technology Conference
on 2017-02-13 as exhibitor
Official Site Inspections
http://www.quintbio.com
- Host name: 172.67.195.43
- IP address: 172.67.195.43
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
